Linked Life Data

17373271

Source:http://linkedlifedata.com/resource/pubmed/id/17373271

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2007-3-21
pubmed:abstractText
Pure red-cell aplasia is an isolated disorder of erythropoiesis that leads to the pment of severe, isolated anemia. In chronic kidney disease patients treated with n erythropoiesis stimulating agent (ESA), development of anti-erythropoietin antibodies s one of the leading causes of pure red-cell aplasia. It requires to stop treatment with ESA, but in the vast majority of cases immunosuppressive therapy is necessary to induce the disappearance of anti-erythropoietin antibodies. Isolated case reports suggest that, at least in some patients, treatments with ESA can be resumed after recovery from antibody-mediated pure red-cell aplasia.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1769-7255
pubmed:author
pubmed:issnType
Print
pubmed:volume
2 Suppl 4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S283-6
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
[Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agents].
pubmed:affiliation
AP-HP (HEGP), université Paris-Descartes, INSERM U652, Paris, France. jerome.rossert@egp.aphp.fr
pubmed:publicationType
Journal Article, English Abstract